ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years

July 30, 1982

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

May 22, 1998

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014

In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing

October 10, 1980

Barney Lepovetsky Dead At 64

April 6, 1990

Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years

May 9, 1997